| BIOGAIA AB B O.N. |
| Schweden |
| Gesundheit |
| SE0017769995 / A3DL7T |
| BGLA (Frankfurt) |
| FRA:BGLA, ETR:BGLA, BGLA:GR |
| - |
| https://www.biogaia.com/ |
|
BioGaia AB (publ) is a Swedish biotechnology and healthcare company specializing in the development, manufacturing, marketing, and sale of probiotic products based on patented Lactobacillus reuteri strains. These products target gut, oral, and immune..
>Volltext.. |
| 1060.67 Mio. EUR |
| 981.21 Mio. EUR |
| 142.17 Mio. EUR |
| 41.46 Mio. EUR |
| 30.56 Mio. EUR |
| 0.3 EUR |
| - |
| 80.25 Mio. EUR |
| 31.41 Mio. EUR |
| 3.27 |
| 8.07% |
| 6.43% |
| 0.37 EUR |
| 1.41% |
| 3.47% |
| 08.05.26 - 0.36668€ 08.05.25 - 0.623829€ >weitere anzeigen... |
| - |
| BIOGAIA |
| 17.07.26 |
|
||||
|